Guo L - Search Results

1

Optimising Outcomes for Glioblastoma through Subspecialisation in a Regional Cancer Centre.

Back M, Jayamanne D, Cove N, Wheeler H, Khasraw M, Guo L, Back J, Wong M. Back M, et al. Among authors: guo l. Brain Sci. 2018 Oct 15;8(10):186. doi: 10.3390/brainsci8100186. Brain Sci. 2018. PMID: 30326653 Free PMC article.

2

Intensity-modulated radiotherapy using simultaneous-integrated boost for definitive treatment of locally advanced mucosal head and neck cancer: outcomes from a single-institution series.

Johnston M, Guo L, Back M, Guminski A, Lee A, Hanna C, Veivers D, Wignall A, Eade T. Johnston M, et al. Among authors: guo l. J Med Imaging Radiat Oncol. 2013 Jun;57(3):356-63. doi: 10.1111/1754-9485.12033. Epub 2013 Jan 17. J Med Imaging Radiat Oncol. 2013. PMID: 23721147 Clinical Trial.

3

Neutrophil-to-lymphocyte ratio in head and neck cancer.

Haddad CR, Guo L, Clarke S, Guminski A, Back M, Eade T. Haddad CR, et al. Among authors: guo l. J Med Imaging Radiat Oncol. 2015 Aug;59(4):514-519. doi: 10.1111/1754-9485.12305. Epub 2015 Apr 23. J Med Imaging Radiat Oncol. 2015. PMID: 25908427

4

Large volume re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high-grade glioma.

Back M, Gzell CE, Kastelan M, Guo L, Wheeler HR. Back M, et al. Among authors: guo l. Neurooncol Pract. 2015 Mar;2(1):48-53. doi: 10.1093/nop/npu031. Epub 2014 Dec 15. Neurooncol Pract. 2015. PMID: 26034641 Free PMC article.

5

Survival improvements with adjuvant therapy in patients with glioblastoma.

Jayamanne D, Wheeler H, Cook R, Teo C, Brazier D, Schembri G, Kastelan M, Guo L, Back MF. Jayamanne D, et al. Among authors: guo l. ANZ J Surg. 2018 Mar;88(3):196-201. doi: 10.1111/ans.14153. Epub 2017 Sep 18. ANZ J Surg. 2018. PMID: 28922698

6

Predicting patterns of failure in temporal lobe GBMs: possible implications on radiotherapy treatment portals.

Jayamanne D, Wheeler H, Brazier D, Newey A, Kastelan M, Guo L, Back M. Jayamanne D, et al. Among authors: guo l. Radiat Oncol. 2018 Jul 20;13(1):133. doi: 10.1186/s13014-018-1078-y. Radiat Oncol. 2018. PMID: 30029668 Free PMC article.

7

Tumour volume reduction following PET guided intensity modulated radiation therapy and temozolomide in IDH mutated anaplastic glioma.

Back M, Jayamanne D, Brazier D, Bailey D, Hsiao E, Guo L, Wheeler H. Back M, et al. Among authors: guo l. J Clin Neurosci. 2019 Jan;59:68-74. doi: 10.1016/j.jocn.2018.11.005. Epub 2018 Nov 14. J Clin Neurosci. 2019. PMID: 30446361

8

Influence of molecular classification in anaplastic glioma for determining outcome and future approach to management.

Back M, Jayamanne DT, Brazier D, Newey A, Bailey D, Schembri GP, Hsiao E, Khasraw M, Wong M, Kastelan M, Guo L, Clarke S, Wheeler H. Back M, et al. Among authors: guo l. J Med Imaging Radiat Oncol. 2019 Apr;63(2):272-280. doi: 10.1111/1754-9485.12850. Epub 2019 Jan 24. J Med Imaging Radiat Oncol. 2019. PMID: 30677248

9

Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma.

Cuncannon M, Wong M, Jayamanne D, Guo L, Cove N, Wheeler H, Back M. Cuncannon M, et al. Among authors: guo l. BMC Cancer. 2019 May 14;19(1):445. doi: 10.1186/s12885-019-5678-1. BMC Cancer. 2019. PMID: 31088401 Free PMC article.

10

Validation of the 8^th edition UICC/AJCC TNM staging system for HPV associated oropharyngeal cancer patients managed with contemporary chemo-radiotherapy.

van Gysen K, Stevens M, Guo L, Jayamanne D, Veivers D, Wignall A, Pang L, Guminski A, Lee A, Hruby G, Macleod P, Taylor A, Eade T. van Gysen K, et al. Among authors: guo l. BMC Cancer. 2019 Jul 9;19(1):674. doi: 10.1186/s12885-019-5894-8. BMC Cancer. 2019. PMID: 31288767 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19,970 results

Search Page